Zhiqing Pang

Fudan University — China

Materials Science · Physical Sciences

75h-index15.9kcitations208works7.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nanoparticle-Based Drug Delivery(79), Nanoplatforms for cancer theranostics(61), RNA Interference and Gene Delivery(60), Extracellular vesicles in disease(28), Advanced biosensing and bioanalysis techniques(16)

Publications208 total

Dual‐Targeting Nanovaccine Eradicates Cancer Stem Cells and Bulk Tumors to Prevent Postoperative Recurrence
MedComm – Biomaterials and Applications·2025Open Access
GDF10 attenuates MASH progression by restoring quiescent hepatic stellate cells via competitive inhibition of TGF-β/SMAD2 signaling
International Journal of Biological Sciences·2025· 1 citedOpen Access
Recent advances in engineering nano/microrobots for tumor treatment
Acta Pharmaceutica Sinica B·2025· 1 citedOpen Access
Artificial intelligence-driven personalized clinical decision-making and drug development in breast cancer
Chinese Chemical Letters·2025
Synergistic enhancement of efferocytosis and cholesterol efflux via macrophage biomimetic nanoparticle to attenuate atherosclerosis progression
Bioactive Materials·2025· 3 citedOpen Access
HIFU‐Driven Targeted Pyroptosis Therapy in Basal‐Like Breast Cancer
Advanced Science·2025Open Access
In vivo neutrophils hitchhiking for tumor targeting and microenvironment regulation boosts oncolytic virus therapy
Cell Reports Medicine·2025· 2 citedOpen Access
Engineered macrophage membrane fusion liposomes carrying siRNA for spatiotemporal regulation of the CCL2/CCR2 axis for cardiac repair
Chinese Chemical Letters·2025
An omics-based drug-HIFU combination therapy discovery for ferroptosis treatment of TNBC
Biomaterials·2025· 2 cited
Lab-in-the-loop machine learning for brain-targeting delivery system design
Cell Biomaterials·2025· 5 citedOpen Access
High intensity forced ultrasound-driven ferroptosis as a strategy for anti-tumor immune priming
Acta Pharmaceutica Sinica B·2025· 6 citedOpen Access
Targeted Delivery of c(RGDfk)‐Modified Liposomes to Bone Marrow Through In Vivo Hitchhiking Neutrophils for Multiple Myeloma Therapy (Adv. Sci. 12/2025)
Advanced Science·2025Open Access
Geometric-aware deep learning enables discovery of bifunctional ligand-based liposomes for tumor targeting therapy
Nano Today·2025· 15 cited
Biomimetic nanoparticles enhanced multiple myeloma treatment by removing chemokine (C-C motif) ligand 3 and synergizing PD-L1 blockade
Chemical Engineering Journal·2025
Targeted Delivery of c(RGDfk)‐Modified Liposomes to Bone Marrow Through In Vivo Hitchhiking Neutrophils for Multiple Myeloma Therapy
Advanced Science·2024· 6 citedOpen Access
Augmenting Tumor Lysis and Immune Response through HIFU-armed Oncolytic Virus Delivery System
Nano Today·2024· 5 cited
Tumor cell membrane biomimetic liposomes-coated oncolytic viruses to target the homotypic tumor and augment the antitumor efficacy
Chinese Chemical Letters·2024· 4 cited
AI-powered omics-based drug pair discovery for pyroptosis therapy targeting triple-negative breast cancer
Nature Communications·2024· 44 citedOpen Access
Advancing cancer nanomedicine with machine learning
Acta Pharmaceutica Sinica B·2024· 2 citedOpen Access
Differential releasing hydrogel loaded with oncolytic viruses and anti-CAFs drug to enhance oncology therapeutic efficacy
Chinese Chemical Letters·2024· 2 cited
page 1 of 11Next →

Frequent Co-authors

Xinguo Jiang(25), Huile Gao(12), Shun Shen(10), Xiaoling Gao(9), Guangzhi Gu(8), Wuli Yang(8), Qizhi Zhang(8), Zhongyang Liu(7), Qingxiang Song(7), Quanyin Hu(7), Zhi Yang(6), Jun Chen(6), Hongzhuan Chen(6), Shijie Cao(5), Huimin Xia(5), Qin Jiang(5), Liangran Guo(5), Shuaiqi Pan(5), Ting Kang(5), Lei Yao(4)